SF Healthcare Week: Biohaven's Chairman & CEO Vlad Coric shares updates on the company's pipeline in immunology, obesity, and epilepsy
BiotechTV - News
00:00
Inconsistencies at FDA for rare diseases
Vlad argues different FDA divisions apply inconsistent standards and stresses need for flexibility in rare disease approvals.
Play episode from 02:37
Transcript
